CSTL - CIK 0001447362
CASTLE BIOSCIENCES INC (CSTL) reported net income of -$24.16M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$24.16M | -232.4% |
| FY 2024 | $18.25M | +131.7% |
| FY 2023 | -$57.47M | +14.4% |
| FY 2022 | -$67.14M | -114.6% |
| FY 2021 | -$31.29M | -204.3% |
| FY 2020 | -$10.28M | -294.9% |
| FY 2019 | $5.28M | +182.9% |
| FY 2018 | -$6.37M | - |
CASTLE BIOSCIENCES INC (CSTL) reported net income of -$24.16M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2018 and fiscal 2025, CASTLE BIOSCIENCES INC's net income declined from -$6.37M to -$24.16M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.